adenosine diphosphate has been researched along with Aortic Stenosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marchandot, B; Matsushita, K; Morel, O; Ohlmann, P; Trimaille, A | 1 |
| Collet, JP; Guedeney, P; Montalescot, G; Van Belle, E; Vicaut, E | 1 |
| Alhayja'a, RA; Dumont, É; Lefebvre-Desjardins, M; Paradis, JM; Pibarot, P; Rodés-Cabau, J | 1 |
| Andriessen, FPJ; Houthuizen, P; Johnson, NP; Leuverman, J; Pijls, NHJ; Scharnhorst, V; Tonino, PAL; Van 't Veer, M; Van de Ven, J; Zelis, JM; Zimmermann, FM | 1 |
| Lentz, SR; Zahr, FE | 1 |
| Auffray, JL; Bauchart, JJ; Bodart, JC; Caron, C; Caspar, T; Corseaux, D; Dallongeville, J; Dally, JB; Debry, N; Delhaye, C; Duhamel, A; Dumonteil, N; Dupont-Prado, A; Goudemand, J; Hermoire, S; Hurt, C; Jeanpierre, E; Juthier, F; Kibler, M; Labreuche, J; Legendre, P; Lemesle, G; Lenting, PJ; Leroy, F; Levade, M; Loobuyck, V; Manchuelle, A; Marchant, B; Morel, O; Mouquet, F; Moussa, K; Paris, C; Rauch, A; Robin, E; Rousse, N; Schurtz, G; Staels, B; Susen, S; Van Belle, E; Vincent, F; Vincentelli, A; Zawadzki, C | 1 |
| Badr Eslam, R; Budde, U; Eichelberger, B; Kaider, A; Koren, D; Lang, IM; Panzer, S; Rosenhek, R; Schneller, A | 1 |
| Feindt, P; Litmathe, J; Sucker, C; Zotz, R | 1 |
| Blostein, MD; D'Souza, PM | 1 |
| Chirkov, YY; Holmes, AS; Horowitz, JD; Stewart, S; Willoughby, SR | 1 |
| Chandy, S; Chirkov, YY; Holmes, AS; Horowitz, JD; Kanna, R; Mishra, K | 1 |
| Hempelmann, G; Kling, D; Podzuweit, T; Schäfer, H; Scheld, HH; von Bormann, B; Weidler, B | 1 |
| Caldarera, CM; Guarnieri, C; Muscari, C | 1 |
| Abidov, AA; Salakhova, NS | 1 |
| Davies, H; Genton, E; Steele, PP; Weily, HS | 1 |
15 other study(ies) available for adenosine diphosphate and Aortic Stenosis
| Article | Year |
|---|---|
Oral Anticoagulant Dose Adjustment After TAVR: The Role of Closure Time With Adenosine Diphosphate.
Topics: Adenosine Diphosphate; Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Humans; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2022 |
Reply: Oral Anticoagulant Dose Adjustment After TAVR: The Role of Closure Time With Adenosine Diphosphate.
Topics: Adenosine Diphosphate; Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Humans; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2022 |
To Turn Over Rocks for Transcatheter Aortic Valve Replacement: Closure Time With Adenosine Diphosphate to Support Decisions in a Complex Transcatheter Aortic Valve-in-Valve Procedure.
Topics: Adenosine Diphosphate; Aged, 80 and over; Aortic Valve Stenosis; Female; Humans; Severity of Illness Index; Time Factors; Transcatheter Aortic Valve Replacement | 2019 |
Assessment of exercise-induced changes in von Willebrand factor as a marker of severity of aortic stenosis.
Topics: Adenosine Diphosphate; Aged; Aortic Valve Stenosis; Bicycling; Biomarkers; Echocardiography, Stress; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Severity of Illness Index; Time Factors; von Willebrand Factor | 2020 |
Von Willebrand Factor--A Rapid Sensor of Paravalvular Regurgitation during TAVR?
Topics: Adenosine Diphosphate; Aortic Valve Insufficiency; Aortic Valve Stenosis; Female; Humans; Male; Postoperative Complications; Transcatheter Aortic Valve Replacement; von Willebrand Factor | 2016 |
Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Biomarkers; Female; Hemostasis; Humans; Male; Multivariate Analysis; Point-of-Care Testing; Postoperative Complications; ROC Curve; Sensitivity and Specificity; Transcatheter Aortic Valve Replacement; von Willebrand Factor | 2016 |
Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; P-Selectin; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Prospective Studies; Protein Multimerization; von Willebrand Factor | 2010 |
Platelet function analyzer (PFA-100) as a useful tool for the prediction of transfusion requirements during aortic valve replacement.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Blood Loss, Surgical; Blood Transfusion; Collagen; Epinephrine; Equipment Design; Female; Germany; Heart Valve Prosthesis Implantation; Hemostasis; Humans; Intraoperative Care; Male; Middle Aged; Platelet Function Tests; Predictive Value of Tests; Preoperative Care; Regression Analysis; Risk Assessment; Risk Factors | 2011 |
Diagnosis of Heyde's syndrome by abnormal closure times despite normal von Willebrand's activity.
Topics: Adenosine Diphosphate; Aged; Aortic Valve; Aortic Valve Stenosis; Blood Coagulation Tests; Collagen; Epinephrine; Factor VIII; Gastrointestinal Hemorrhage; Humans; Male; Platelet Aggregation; Ristocetin; von Willebrand Diseases; von Willebrand Factor | 2011 |
Association of aortic stenosis with platelet hyperaggregability and impaired responsiveness to nitric oxide.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Cardiovascular Agents; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; Perhexiline; Platelet Aggregation; Platelet Aggregation Inhibitors; Severity of Illness Index; Statistics as Topic; Stroke Volume; Ventricular Function, Left | 2002 |
Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
Topics: Adenosine Diphosphate; Aged; Alprostadil; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Biomarkers; Blood Platelets; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Female; Humans; Male; Middle Aged; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Research Design | 2006 |
[Effect of aspartate compounds on the biochemical characteristics of myocardial energy metabolism in man].
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspartic Acid; Energy Metabolism; Female; Heart; Heart Valve Prosthesis; Humans; Isotonic Solutions; Lactates; Lactic Acid; Male; Middle Aged; Myocardium; Phosphocreatine; Ringer's Solution | 1983 |
Oxygen radicals and tissue damage in heart hypertrophy.
Topics: Adenosine Diphosphate; Animals; Aortic Valve Stenosis; Cardiomegaly; Hydrogen Peroxide; In Vitro Techniques; Male; Mitochondria, Heart; Myocardium; NAD; Oxygen Consumption; Potassium Cyanide; Rabbits; Succinates; Superoxides | 1985 |
[Lipid metabolism and adenine nucleotide concentration in heart muscle in experimental aortic stenosis].
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Aortic Valve Stenosis; Cardiomegaly; Fatty Acids, Nonesterified; Myocardium; Oxygen Consumption; Rabbits; Triglycerides | 1973 |
Platelet survival in patients with rheumatic heart disease.
Topics: Adenosine Diphosphate; Aortic Valve Stenosis; Blood Platelets; Cell Survival; Chromium Radioisotopes; Collagen; Humans; Mitral Valve Insufficiency; Mitral Valve Stenosis; Platelet Adhesiveness; Rheumatic Heart Disease; Sulfinpyrazone; Thromboembolism; Time Factors | 1974 |